{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:39:24Z","timestamp":1793165964015,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jcms.2017.05.028","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T20:15:54Z","timestamp":1496520954000},"page":"1493-1502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review"],"prefix":"10.1016","volume":"45","author":[{"given":"Suad","family":"Aljohani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham","family":"Fliefel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Ihbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"K\u00fchnisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ehrenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcms.2017.05.028_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10006-005-0670-0","article-title":"[Bisphosphonate-associated osteonecrosis of the jaw]","volume":"10","author":"Abu-Id","year":"2006","journal-title":"Mund Kiefer Gesichtschir"},{"key":"10.1016\/j.jcms.2017.05.028_bib2","first-page":"1233","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates. Discussion over 52 cases","volume":"52","author":"Almasan","year":"2011","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.jcms.2017.05.028_bib3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.oooo.2013.03.001","article-title":"Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis","volume":"115","author":"Anavi-Lev","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jcms.2017.05.028_bib4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10103-009-0654-7","article-title":"Osteonecrosis of the jaws caused by bisphosphonates: evaluation of a new therapeutic approach using the er:Yag laser","volume":"24","author":"Angiero","year":"2009","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.jcms.2017.05.028_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.joms.2009.01.003","article-title":"Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies","volume":"67","author":"Assael","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/odi.12447","article-title":"Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis","volume":"22","author":"Bagan","year":"2016","journal-title":"Oral Dis"},{"key":"10.1016\/j.jcms.2017.05.028_bib7","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcms.2017.05.028_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1359\/JBMR.041007","article-title":"Osteoporosis and fracture risk in women of different ethnic groups","volume":"20","author":"Barrett-Connor","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2017.05.028_bib9","doi-asserted-by":"crossref","first-page":"e948","DOI":"10.4317\/medoral.17946","article-title":"Bone metabolism and clinical study of 44 patients with bisphosphonate-related osteonecrosis of the jaws","volume":"17","author":"Bocanegra-Perez","year":"2012","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.jcms.2017.05.028_bib10","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/jc.2013-1597","article-title":"The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the freedom extension","volume":"98","author":"Bone","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcms.2017.05.028_bib11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.joms.2009.12.030","article-title":"Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw \u2013 a serial case analysis","volume":"68","author":"Chiu","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib12","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1210\/jc.2013-4119","article-title":"The risk of osteonecrosis of the jaws in Taiwanese osteoporotic patients treated with oral alendronate or raloxifene","volume":"99","author":"Chiu","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcms.2017.05.028_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01623184","article-title":"Hip fractures in the elderly: a world-wide projection","volume":"2","author":"Cooper","year":"1992","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcms.2017.05.028_bib14","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcms.2017.05.028_bib15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcms.2017.05.028_bib16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ejim.2013.05.011","article-title":"Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases","volume":"24","author":"Di Fede","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jcms.2017.05.028_bib17","doi-asserted-by":"crossref","first-page":"e751","DOI":"10.4317\/medoral.18041","article-title":"Oral bisphosphonate-related osteonecrosis of the jaws: clinical characteristics of a series of 20 cases in Spain","volume":"17","author":"Diniz-Freitas","year":"2012","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.jcms.2017.05.028_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.mlg.0000187398.51857.3c","article-title":"Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates","volume":"116","author":"Farrugia","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jcms.2017.05.028_bib19","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3899\/jrheum.090455","article-title":"Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients","volume":"36","author":"Favia","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jcms.2017.05.028_bib20","first-page":"433","article-title":"Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: report of eight cases","volume":"47","author":"Favia","year":"2016","journal-title":"Quintessence Int"},{"key":"10.1016\/j.jcms.2017.05.028_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijom.2015.01.026","article-title":"Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (bronj) with characterization of patients: a systematic review","volume":"44","author":"Fliefel","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/SCS.0000000000002564","article-title":"Medication-related osteonecrosis of the jaw around dental implants: implant surgery-triggered or implant presence-triggered osteonecrosis?","volume":"27","author":"Giovannacci","year":"2016","journal-title":"J\u00a0Craniofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.joms.2009.09.037","article-title":"The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a south Australian case series","volume":"68","author":"Goss","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib24","first-page":"52","article-title":"The epidemiology of osteoporosis\u2013bone evaluation study (best): an analysis of routine health insurance data","volume":"110","author":"Hadji","year":"2013","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jcms.2017.05.028_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.oooo.2014.05.006","article-title":"Osteonecrosis of the jaw in patients treated with oral and intravenous bisphosphonates: experience in Sweden","volume":"118","author":"Hallmer","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jcms.2017.05.028_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00784-009-0300-6","article-title":"Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings","volume":"14","author":"Hoefert","year":"2010","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jcms.2017.05.028_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00198-009-1024-9","article-title":"Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia","volume":"21","author":"Hong","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcms.2017.05.028_bib28","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.joms.2010.05.003","article-title":"Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure","volume":"68","author":"Hutchinson","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib29","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ijom.2012.05.012","article-title":"The outcomes of conservative and surgical treatment of stage 2 bisphosphonate-related osteonecrosis of the jaws: a case series","volume":"41","author":"Jabbour","year":"2012","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib30","doi-asserted-by":"crossref","first-page":"w13605","DOI":"10.4414\/smw.2012.13605","article-title":"Osteopathology of the jaw associated with bone resorption inhibitors: what have we learned in the last 8 years?","volume":"142","author":"Jacobsen","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jcms.2017.05.028_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00784-012-0708-2","article-title":"Osteopathology induced by bisphosphonates and dental implants: clinical observations","volume":"17","author":"Jacobsen","year":"2013","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jcms.2017.05.028_bib32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0022034515572021","article-title":"Infection and medication-related osteonecrosis of the jaw","volume":"94","author":"Katsarelis","year":"2015","journal-title":"J\u00a0Dent Res"},{"key":"10.1016\/j.jcms.2017.05.028_bib33","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0025-6196(11)60752-0","article-title":"Adverse effects of bisphosphonates: implications for osteoporosis management","volume":"84","author":"Kennel","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jcms.2017.05.028_bib34","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","article-title":"Possible association between diabetes and bisphosphonate-related jaw osteonecrosis","volume":"92","author":"Khamaisi","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcms.2017.05.028_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2017.05.028_bib36","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American society for bone and mineral research","volume":"22","author":"Khosla","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2017.05.028_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5125\/jkaoms.2016.42.4.193","article-title":"Evaluation of the predisposing factors and involved outcome of surgical treatment in bisphosphonate-related osteonecrosis of the jaw cases including bone biopsies","volume":"42","author":"Kim","year":"2016","journal-title":"J\u00a0Korean Assoc Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib38","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"Klibanski","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jcms.2017.05.028_bib39","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jcms.2015.04.018","article-title":"Bisphosphonates enhance bacterial adhesion and biofilm formation on bone hydroxyapatite","volume":"43","author":"Kos","year":"2015","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/clr.12088","article-title":"Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment","volume":"25","author":"Kwon","year":"2014","journal-title":"Clin Oral Implant. Res"},{"key":"10.1016\/j.jcms.2017.05.028_bib41","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.oraloncology.2008.11.010","article-title":"Collagen telopeptide (serum ctx) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates","volume":"45","author":"Kwon","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jcms.2017.05.028_bib42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2010.05835.x","article-title":"Potential pathophysiological mechanisms in osteonecrosis of the jaw","volume":"1218","author":"Landesberg","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jcms.2017.05.028_bib43","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","article-title":"Epidemiology, etiology, and diagnosis of osteoporosis","volume":"194","author":"Lane","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jcms.2017.05.028_bib44","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.joms.2008.11.015","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients","volume":"67","author":"Lazarovici","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib45","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.joms.2009.09.017","article-title":"Bisphosphonate-related osteonecrosis of the jaw associated with dental implants","volume":"68","author":"Lazarovici","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib46","first-page":"227","article-title":"Medication-related osteonecrosis of the jaws from once per year intravenous zoledronic acid (reclast): report of 4 cases","volume":"24","author":"Lee","year":"2015","journal-title":"Implant Dent"},{"key":"10.1016\/j.jcms.2017.05.028_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Go AS and predicting risk of osteonecrosis of the jaw with Oral bisphosphonate exposure I: prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib48","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/scs.0b013e3180f611ef","article-title":"Surgical therapy for osteonecotic lesions of the jaws in patients in therapy with bisphosphonates","volume":"18","author":"Longobardi","year":"2007","journal-title":"J\u00a0Craniofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib49","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.bjoms.2013.06.011","article-title":"Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series","volume":"51","author":"Lopez-Cedrun","year":"2013","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib50","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.oooo.2012.08.439","article-title":"The relationship of denosumab pharmacology and osteonecrosis of the jaws","volume":"114","author":"Malan","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jcms.2017.05.028_bib51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijom.2010.11.002","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis","volume":"40","author":"Manfredi","year":"2011","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib52","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum ctx testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib54","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00223-013-9747-1","article-title":"Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series","volume":"93","author":"Mercer","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jcms.2017.05.028_bib55","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the prisma statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open Med"},{"key":"10.1016\/j.jcms.2017.05.028_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00198-013-2437-z","article-title":"Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab","volume":"25","author":"Neuprez","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcms.2017.05.028_bib57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00223-014-9858-3","article-title":"Teriparatide therapy for denosumab-induced osteonecrosis of the jaw in a male osteoporotic patient","volume":"95","author":"Neuprez","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jcms.2017.05.028_bib58","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2209\/tdcpublication.54.117","article-title":"Bisphosphonate-related osteonecrosis of jaw (bronj) in Japanese population: a case series of 13 patients at our clinic","volume":"54","author":"Nomura","year":"2013","journal-title":"Bull Tokyo Dent Coll"},{"key":"10.1016\/j.jcms.2017.05.028_bib59","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.joms.2011.08.033","article-title":"Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes","volume":"70","author":"O'Ryan","year":"2012","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib60","first-page":"3707","article-title":"Osteonecrosis of the jaw in patient with denosumab therapy","volume":"7","author":"Olate","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jcms.2017.05.028_bib61","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcms.2010.05.009","article-title":"Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence \u2013 a multi-centre study","volume":"39","author":"Otto","year":"2011","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib62","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jcms.2013.05.038","article-title":"Successful surgical management of osteonecrosis of the jaw due to rank-ligand inhibitor treatment using fluorescence guided bone resection","volume":"41","author":"Otto","year":"2013","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib63","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.joms.2009.07.079","article-title":"Bisphosphonate-related osteonecrosis of the jaw: is ph the missing part in the pathogenesis puzzle?","volume":"68","author":"Otto","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0033-1343776","article-title":"Pathologic fractures in bisphosphonate-related osteonecrosis of the jaw-review of the literature and review of our own cases","volume":"6","author":"Otto","year":"2013","journal-title":"Craniomaxillofac Trauma Reconstr"},{"key":"10.1016\/j.jcms.2017.05.028_bib65","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/j.joms.2010.07.017","article-title":"Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism","volume":"68","author":"Otto","year":"2010","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib66","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","article-title":"Bisphosphonate-related osteonecrosis of the jaws \u2013 characteristics, risk factors, clinical features, localization and impact on oncological treatment","volume":"40","author":"Otto","year":"2012","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib67","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","article-title":"Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for bronj development?","volume":"43","author":"Otto","year":"2015","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib68","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.4317\/medoral.19094","article-title":"Alendronate-associated osteonecrosis of the jaws: a review of the main topics","volume":"19","author":"Paiva-Fonseca","year":"2014","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.jcms.2017.05.028_bib69","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jbmr.1479","article-title":"Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the freedom extension","volume":"27","author":"Papapoulos","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2017.05.028_bib70","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00198-015-3234-7","article-title":"The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the freedom extension study","volume":"26","author":"Papapoulos","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcms.2017.05.028_bib71","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00198-009-0973-3","article-title":"Osteonecrosis of the jaw induced by oral administration of bisphosphonates in asian population: five cases","volume":"21","author":"Park","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcms.2017.05.028_bib72","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/jnci\/djq516","article-title":"Osteonecrosis of the jaw and the role of macrophages","volume":"103","author":"Pazianas","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jcms.2017.05.028_bib73","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.4317\/medoral.19458","article-title":"Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: a pilot study comparing fibrin rich in growth factors and teriparatide","volume":"19","author":"Pelaz","year":"2014","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.jcms.2017.05.028_bib74","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.jcms.2012.10.014","article-title":"Denosumab osteonecrosis of the mandible: a new entity? A case report","volume":"41","author":"Pichardo","year":"2013","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib75","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.oooo.2013.05.005","article-title":"Bisphosphonate related osteonecrosis of the jaws: spontaneous or dental origin?","volume":"116","author":"Pichardo","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jcms.2017.05.028_bib76","first-page":"5070187","article-title":"Denosumab related osteonecrosis of the jaw with spontaneous necrosis of the soft palate: report of a life threatening case","volume":"2016","author":"Qaisi","year":"2016","journal-title":"Case Rep Dent"},{"key":"10.1016\/j.jcms.2017.05.028_bib77","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.mayocp.2013.01.002","article-title":"Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy","volume":"88","author":"Rachner","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jcms.2017.05.028_bib78","doi-asserted-by":"crossref","first-page":"471035","DOI":"10.1155\/2014\/471035","article-title":"Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment","volume":"2014","author":"Rasmusson","year":"2014","journal-title":"Int J Dent"},{"key":"10.1016\/j.jcms.2017.05.028_bib79","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw \u2013 2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib80","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1747-4477.2009.00213.x","article-title":"American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaw \u2013 2009 update","volume":"35","author":"Ruggiero","year":"2009","journal-title":"Aust Endod J"},{"key":"10.1016\/j.jcms.2017.05.028_bib81","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib82","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/lary.20076","article-title":"Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: a Belgian case series","volume":"119","author":"Saussez","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jcms.2017.05.028_bib83","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14219\/jada.archive.2009.0019","article-title":"Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"J\u00a0Am Dent Assoc"},{"key":"10.1016\/j.jcms.2017.05.028_bib84","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.14219\/jada.archive.2009.0049","article-title":"Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"J\u00a0Am Dent Assoc"},{"key":"10.1016\/j.jcms.2017.05.028_bib85","first-page":"2670","article-title":"Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer","volume":"182","author":"Smith","year":"2009","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jcms.2017.05.028_bib86","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.joms.2008.12.057","article-title":"Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases","volume":"67","author":"Stanton","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib87","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00198-014-2964-2","article-title":"Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the denosumab fracture intervention randomized placebo controlled trial (direct)","volume":"26","author":"Sugimoto","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcms.2017.05.028_bib88","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","article-title":"Osteonecrosis of the jaws induced by anti-rank ligand therapy","volume":"48","author":"Taylor","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib89","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.joms.2013.06.221","article-title":"Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate","volume":"72","author":"Ulmner","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib90","first-page":"2014","article-title":"Conservative surgical management of stage i bisphosphonate-related osteonecrosis of the jaw","volume":"107690","author":"Vescovi","year":"2014","journal-title":"Int J Dent"},{"key":"10.1016\/j.jcms.2017.05.028_bib91","first-page":"2011","article-title":"Osteoporosis and bisphosphonate-related osteonecrosis of the jaw bone","volume":"654027","author":"Villa","year":"2011","journal-title":"ISRN Rheumatol"},{"key":"10.1016\/j.jcms.2017.05.028_bib92","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jcms.2012.01.005","article-title":"Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients","volume":"40","author":"Voss","year":"2012","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2017.05.028_bib93","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.eururo.2008.06.070","article-title":"Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate","volume":"54","author":"Walter","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.jcms.2017.05.028_bib94","series-title":"Prevention and management of osteoporosis","author":"WHO","year":"2003"},{"key":"10.1016\/j.jcms.2017.05.028_bib95","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1345\/aph.1K652","article-title":"Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis","volume":"42","author":"Woodis","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jcms.2017.05.028_bib96","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bone.2012.08.115","article-title":"Risk of osteomyelitis of the jaw induced by oral bisphosphonates in patients taking medications for osteoporosis: a hospital-based cohort study in Japan","volume":"51","author":"Yamazaki","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.jcms.2017.05.028_bib97","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-007-0384-2","article-title":"Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome","volume":"18","author":"Yarom","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcms.2017.05.028_bib98","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.oooo.2015.07.017","article-title":"Denosumab-related osteonecrosis of the jaw: a case report and management based on pharmacokinetics","volume":"120","author":"You","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jcms.2017.05.028_bib99","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/GME.0000000000000466","article-title":"Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis","volume":"22","author":"Zhang","year":"2015","journal-title":"Menopause"}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518217301944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518217301944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:38:01Z","timestamp":1760884681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518217301944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":99,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1010518217301944"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2017.05.028","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2017.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}